28.04.2011 • News

Hungary Could Raise Drug Sales Tax To 20%

Hungary's government may raise the tax payable by drug companies on state-subsidized drug sales to 20%, not 18% as previously planned, a pharmaceuticals sector source told Reuters on Wednesday. The tax is currently 12%.

"The latest we've heard it's going to be 20%," the source, who spoke on condition of anonymity, said.

The tax increase is part of the government's efforts to slash the more-than-300-billion-forint ($1.66 billion) state drug fund by 120 billion forints by 2013 in a drive to keep the budget deficit below 3% of economic output.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.